SCHEMBL7488781

SCHEMBL7488781

CCOC(=O)COc1cccc(CC2=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)C3CCC2C3)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 13/20 0.52
PTGER4 P35408 4/20 0.49
PTGER3 P43115 2/20 0.49
FABP4 P15090 1/20 0.47
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
KMT2A Q03164 1/20 0.45
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
TBXA2R P21731 1/20 0.42
PTGER2 P43116 1/20 0.42
PTGDR Q13258 1/20 0.42
PPARG P37231 3/20 0.40
PPARA Q07869 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7490977 0.90 FABP4 (0.58) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7493731 0.84 PTGIR (0.44) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7960373 0.80 PTGIR (0.59) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7949669 0.80 PTGIR (0.49) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7957475 0.79 PTGIR (0.43) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7949757 0.79 PTGIR (0.51) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL8072043 0.78 FABP4 (0.61) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7487196 0.78 PTGIR (0.74) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7487189 0.78 PTGIR (0.74) PTGIRPTGER4PTGER3FABP4KDM4E
SCHEMBL7959804 0.76 PTGER4 (0.48) PTGIRPTGER4PTGER3FABP4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed